Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin C Michel

Showing results (11-20 of 341) with videos related to

Pageof 35
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 25, 2006
An anthology from Naunyn-Schmiedeberg's Archives of PharmacologyMartin C Michel
BMJ (Clinical Research Ed.)|July 18, 2012
Post-marketing studies can make important contributions to medical knowledgeMartin C Michel
Drug Safety|September 21, 2002
A benefit-risk assessment of extended-release oxybutyninMartin C Michel
BJU International|June 30, 2015
Cellular basis of detrusor smooth muscle contractionMartin C Michel
MMW Fortschritte Der Medizin|April 5, 2017
[How can innovative medicines stay affordable?]Martin C Michel
Idrugs : the Investigational Drugs Journal|December 23, 2003
Lower urinary tract disorders - Ray Fuller SymposiumMartin C Michel
BJU International|August 5, 2004
Ejaculatory dysfunction and alpha-adrenoceptor antagonistsMartin C Michel
The Journal of Urology|June 17, 2008
Re: Ghost writers in the skyMartin C Michel
European Urology|September 11, 2023
Re: Genetically Adjusted PSA Levels for Prostate Cancer ScreeningMartin C Michel
European Journal of Pharmacology|October 10, 2020
α<sub>1</sub>-adrenoceptor activity of β-adrenoceptor ligands - An expected drug property with limited clinical relevanceMartin C Michel
Pageof 35

Showing results (11-20 of 341) with videos related to

Sort By:
Pageof 35
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 25, 2006
An anthology from Naunyn-Schmiedeberg's Archives of PharmacologyMartin C Michel
BMJ (Clinical Research Ed.)|July 18, 2012
Post-marketing studies can make important contributions to medical knowledgeMartin C Michel
Drug Safety|September 21, 2002
A benefit-risk assessment of extended-release oxybutyninMartin C Michel
BJU International|June 30, 2015
Cellular basis of detrusor smooth muscle contractionMartin C Michel
MMW Fortschritte Der Medizin|April 5, 2017
[How can innovative medicines stay affordable?]Martin C Michel
Idrugs : the Investigational Drugs Journal|December 23, 2003
Lower urinary tract disorders - Ray Fuller SymposiumMartin C Michel
BJU International|August 5, 2004
Ejaculatory dysfunction and alpha-adrenoceptor antagonistsMartin C Michel
The Journal of Urology|June 17, 2008
Re: Ghost writers in the skyMartin C Michel
European Urology|September 11, 2023
Re: Genetically Adjusted PSA Levels for Prostate Cancer ScreeningMartin C Michel
European Journal of Pharmacology|October 10, 2020
α<sub>1</sub>-adrenoceptor activity of β-adrenoceptor ligands - An expected drug property with limited clinical relevanceMartin C Michel
Pageof 35